Apimeds Pharmaceuticals Us, Stock Alpha and Beta Analysis
| APUS Stock | 1.93 0.05 2.53% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Apimeds Pharmaceuticals US,. It also helps investors analyze the systematic and unsystematic risks associated with investing in Apimeds Pharmaceuticals over a specified time horizon. Remember, high Apimeds Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Apimeds Pharmaceuticals' market risk premium analysis include:
Beta 0.69 | Alpha (0.08) | Risk 6.36 | Sharpe Ratio 0.0458 | Expected Return 0.29 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Apimeds Pharmaceuticals Backtesting, Apimeds Pharmaceuticals Valuation, Apimeds Pharmaceuticals Correlation, Apimeds Pharmaceuticals Hype Analysis, Apimeds Pharmaceuticals Volatility, Apimeds Pharmaceuticals History and analyze Apimeds Pharmaceuticals Performance. Apimeds Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Apimeds Pharmaceuticals market risk premium is the additional return an investor will receive from holding Apimeds Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Apimeds Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Apimeds Pharmaceuticals' performance over market.| α | -0.08 | β | 0.69 |
Apimeds Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Apimeds Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Apimeds Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Apimeds Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Apimeds Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Apimeds Pharmaceuticals shares will generate the highest return on investment. By understating and applying Apimeds Pharmaceuticals stock market price indicators, traders can identify Apimeds Pharmaceuticals position entry and exit signals to maximize returns.
Apimeds Pharmaceuticals Return and Market Media
The median price of Apimeds Pharmaceuticals for the period between Wed, Jul 30, 2025 and Tue, Oct 28, 2025 is 1.84 with a coefficient of variation of 8.29. The daily time series for the period is distributed with a sample standard deviation of 0.15, arithmetic mean of 1.84, and mean deviation of 0.11. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | What Fibonacci levels say about Apimeds Pharmaceuticals US Inc. rebound - 2025 Institutional Moves Weekly Watchlist for Consistent Profits - Newser | 08/26/2025 |
2 | Is Apimeds Pharmaceuticals US Inc. trending in predictive chart models - Take Profit Growth Focused Stock Pick Reports - Newser | 09/04/2025 |
3 | Technical Heatmap Flags Apimeds Pharmaceuticals US Inc. for Watch - July 2025 Sentiment Low Risk High Win Rate Picks - beatles.ru | 09/08/2025 |
4 | Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program | 09/12/2025 |
5 | Growth Value Is Apimeds Pharmaceuticals US Inc benefiting from innovation trends - Market Risk Summary Free Safe Capital Growth Stock Tips - | 09/18/2025 |
6 | Is Apimeds Pharmaceuticals US Inc. stock positioned for secular growth - Weekly Volume Report Weekly Breakout Opportunity Watchlist - newser.com | 10/01/2025 |
7 | Apimeds Pharmaceuticals US Inc. stock trend outlook and recovery path - Weekly Profit Report Fast Exit and Entry Strategy Plans - newser.com | 10/13/2025 |
8 | Acquisition by Erik Emerson of 215000 shares of Apimeds Pharmaceuticals at 1.92 subject to Rule 16b-3 | 10/15/2025 |
9 | Apimeds Pharmaceuticals Amends Bylaws for Shareholder Consent - TipRanks | 10/16/2025 |
10 | Is it too late to sell Apimeds Pharmaceuticals US Inc. - 2025 Price Action Summary Safe Swing Trade Setup Alerts - newser.com | 10/20/2025 |
About Apimeds Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Apimeds or other stocks. Alpha measures the amount that position in Apimeds Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Apimeds Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Apimeds Pharmaceuticals' short interest history, or implied volatility extrapolated from Apimeds Pharmaceuticals options trading.
Build Portfolio with Apimeds Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Apimeds Stock Analysis
When running Apimeds Pharmaceuticals' price analysis, check to measure Apimeds Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apimeds Pharmaceuticals is operating at the current time. Most of Apimeds Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apimeds Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apimeds Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apimeds Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.